Cargando…

Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing

Detalles Bibliográficos
Autores principales:	Rebic, Nevena, Munro, Sarah, Norman, Wendy V., Soon, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Research and Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165881/ https://www.ncbi.nlm.nih.gov/pubmed/34104270 http://dx.doi.org/10.1177/17151635211005503

Ejemplares similares

Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022)

Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019)

“Now what?!” A practice tool for pharmacist-driven options counselling for unintended pregnancy
por: Rebić, Nevena, et al.
Publicado: (2021)

Could implementation of mifepristone address Canada’s urban–rural abortion access disparity: a mixed-methods implementation study protocol
por: Norman, Wendy V, et al.
Publicado: (2019)

Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
por: Munro, Sarah, et al.
Publicado: (2021)

The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States
por: Mark, Alice, et al.
Publicado: (2021)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
por: Wiebe, Ellen R, et al.
Publicado: (2020)

Mifepristone Antagonization with Progesterone to Avert Medication Abortion: A Scoping Review
por: DeBeasi, Paul L. C.
Publicado: (2023)

Medical abortion with mifepristone and home administration of misoprostol up to 63 days’ gestation
por: Løkeland, Mette, et al.
Publicado: (2014)

Early medical abortion with self‐administered low‐dose mifepristone in combination with misoprostol
por: Song, Li‐Ping, et al.
Publicado: (2018)

Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: Zhao, Xiaoying, et al.
Publicado: (2021)

Subsequent placenta accreta after previous mifepristone-induced abortion: A case report
por: Zhao, Peng, et al.
Publicado: (2021)

The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
por: Wang, Kai, et al.
Publicado: (2022)

Retracted: Clinical Efficacy and Safety Study of Mifepristone with Misoprostol Treatment in Patients with Missed Abortion
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Perspective of Rural Physicians Providing Abortion in Canada: Qualitative Findings of the BC Abortion Providers Survey (BCAPS)
por: Dressler, Jennifer, et al.
Publicado: (2013)

Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortion Providers Survey (BCAPS)
por: Norman, Wendy V., et al.
Publicado: (2013)

Determination of Mifepristone (RU-486) and Its Metabolites in Maternal Blood Sample after Pharmacological Abortion
por: Szpot, Paweł, et al.
Publicado: (2022)

Leadership for success in transforming medical abortion policy in Canada
por: Dineley, Brigid, et al.
Publicado: (2020)

Trends in medication abortion and the role of low-volume and nonmetropolitan mifepristone purchasers: 2008–2011 and 2014–2017()
por: Jones, Rachel K.
Publicado: (2020)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

A Virtual Community of Practice to Support Physician Uptake of a Novel Abortion Practice: Mixed Methods Case Study
por: Dunn, Sheila, et al.
Publicado: (2022)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

A Retrospective Cost-Effectiveness Analysis of Mifepristone–Misoprostol Medical Abortions in the First Year at the Regina General Hospital
por: Hunter, Caitlin, et al.
Publicado: (2021)

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
por: Studnicki, James, et al.
Publicado: (2021)

EXPRESSION OF CONCERN: A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions
Publicado: (2023)

Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa
por: Constant, Deborah, et al.
Publicado: (2016)

Comparison of mifepristone plus misoprostol with misoprostol alone for first trimester medical abortion: A systematic review and meta-analysis
por: Shimels, Tariku, et al.
Publicado: (2023)

Exploring the impact of mifepristone’s risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics()
por: Razon, Na’amah, et al.
Publicado: (2022)

The Physical Activity Messaging Framework (PAMF) and Checklist (PAMC): International consensus statement and user guide
por: Williamson, Chloë, et al.
Publicado: (2021)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

The project manager's guide and checklists: guidance and checklists for engineering and construction
por: Ward, Garth G F
Publicado: (2018)

Access to Complex Abortion Care Service and Planning Improved through a Toll-Free Telephone Resource Line
por: Norman, Wendy V., et al.
Publicado: (2014)

Development and pilot testing of the 2019 Canadian Abortion Provider Survey
por: Renner, Regina M., et al.
Publicado: (2023)

Nurse practitioners on ‘the leading edge’ of medication abortion care: A feminist qualitative approach
por: Carson, Andrea, et al.
Publicado: (2022)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0agnipr28r7bq6ohabn028va3p